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Mendelian randomization (MR) has become a popular approach
to study the effect of a modifiable exposure on an outcome by using
genetic variants as instrumental variables. A challenge in MR is that
each genetic variant explains a relatively small proportion of variance
in the exposure and there are many such variants, a setting known
as many weak instruments. To this end, we provide a full theoretical
characterization of the statistical properties of the two popular esti-
mators in MR, the inverse-variance weighted (IVW) estimator and
the pre-screened IVW estimator with instruments selected from an in-
dependent selection dataset, under many weak instruments. We then
propose a debiased IVW estimator, a simple modification of the IVW
estimator, that is robust to many weak instruments and doesn’t re-
quire pre-screening. Additionally, we present two instrument selection
methods to improve efficiency of the new estimator when a selection
dataset is available. An extension of the debiased IVW estimator to
handle balanced horizontal pleiotropy is also discussed. We conclude
by demonstrating our results in simulated and real datasets.
1. Introduction.
1.1. Motivation: Many Weak Instruments in MR. Instrumental variable
(IV) is a well-known method to handle unmeasured confounding in obser-
vational studies [5, 25, 4]. Mendelian randomization (MR), a type of IV
method, utilizes genetic variants as instruments to study the effect of a
modifiable exposure or potential risk factor on an outcome in the presence
of unmeasured confounding [19, 32, 27, 26, 11, 18, 42, 30]. A distinct feature
of MR is that there can be a large number of genetic variants, specifically sin-
gle nucleotide polymorphisms (SNPs) from pre-existing large genome-wide
association studies (GWASs), and many or possibly all SNPs are weak IVs; it
is also referred to as many weak instruments in econometrics [15]. There are
three primary reasons why SNPs in MR are considered weak instruments.
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First, when SNPs are common genetic variants, i.e., their minor allele fre-
quencies (MAF) are greater than 0.05 [21, 16], they may have small effects
on the exposure. Second, when SNPs are rare variants, i.e., their MAF are
less than 0.05, they may have small or modest effects on the exposure, but
their genetic variances are also small so that their estimated effects may be
imprecise. Third, there are often many SNPs that have zero/null effects on
the exposure.
In this article, we focus on a popular setup in MR known as two-sample
summary-data MR, where two sets of summary statistics are obtained from
two GWASs [29]. The first set consists of estimated marginal associations
between p SNPs and the exposure derived from one GWAS, denoted as
γˆj , j = 1, . . . , p. The second set consists of estimated marginal associations
between the same p SNPs and the outcome derived from another GWAS,
denoted as Γˆj , j = 1, . . . , p. In MR, the most popular estimator of the expo-
sure effect on the outcome, denoted as β0, is the inverse-variance weighted
(IVW) estimator [10]
(1.1) βˆIVW =
∑p
j=1wj βˆj∑p
j=1wj
, βˆj =
Γˆj
γˆj
, wj =
γˆ2j
σ2Y j
.
Here, σY j is the standard error of Γˆj , j = 1, ..., p. Despite its widespread
usage, very little is known about the theoretical properties of this estimator,
such as its consistency or asymptotic normality, in common MR setups where
there are many weak IVs, It is known that if a SNP is a weak IV, the ratio
estimator βˆj is biased and its distribution is not well approximated by a
normal distribution [31]. This raises serious questions on the validity of the
IVW estimator βˆIVW, a weighted combination of βˆj , as well as other modern
MR methods using βˆj ’s [10, 6, 7, 22].
To reduce concerns from weak IVs, a widely adopted practice in MR is
to only include SNPs that pass the genome-wide significance threshold (i.e.,
p-value associated with γˆj is less than 5× 10−8 [42]) in the IVW estimator,
say
(1.2) βˆλ,IVW =
∑
j∈Sλ wj βˆj∑
j∈Sλ wj
, Sλ = {k : SNP k is significant}.
More details are given in Section 3.2. While the use of genome-wide sig-
nificance threshold is well-justified in controlling false discovery rates from
testing millions of SNPs [17, 28], there has not been an investigation on
using the same strategy to address the issue of weak IVs in MR studies.
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1.2. Prior Work and Our Contributions. Prior work on weak IVs in MR
is vast, but mostly limited to numerical studies [12, 13, 14, 29, 10]. In econo-
metrics, the issue of weak IVs has been studied, but the results are limited
to one-sample individual-data settings; see Stock, Wright and Yogo [35] and
Andrews and Stock [3] for surveys. Recent works by Zhao et al. [40, 41] and
Bowden et al. [9] proposed new estimators robust to many weak IVs in two-
sample summary-data settings. Also, work by Wang and Kang [38] proposed
new tests when the number of instruments is fixed, but the instruments are
arbitrarily weak. But, to the best of our knowledge, no work has addressed
the theoretical properties of the IVW estimator in (1.1) or its pre-screened
counterpart in (1.2), arguably the most popular estimators in MR, under a
common setting where there are many weak IVs.
Our overarching goal is to characterize the properties of the IVW estima-
tor and to propose some improvements over estimators in (1.1)-(1.2). The
main contributions can be divided into three parts.
1. We provide an asymptotic phase transition analysis of the IVW esti-
mator (1.1) in terms of instruments’ average strength. We conduct a
similar exercise for the pre-screened IVW estimator (1.2).
2. We propose a simple way to improve the IVW estimator (1.1) under
many weak IVs, which we call the debiased IVW (dIVW) estimator.
It is explicitly formulated as the IVW estimator multiplied by a bias
correction factor; see equation (4.1). Unlike the IVW estimator, the
dIVW estimator is robust to many weak IVs. In fact, even without pre-
screening for strong IVs, the dIVW estimator is generally consistent
and asymptotically normal. As such, the dIVW estimator does not
need a third independent GWAS to select strong instruments while
mitigating the “winner’s curse” bias [40, 10]. Finally, our dIVW esti-
mator stands in contrast to recent optimization-based estimators (e.g.,
[41]) that are robust to many weak IVs, but are arguably more complex
than the dIVW estimator. Specifically, these optimization-based esti-
mators do not have explicit forms and may not have unique estimates
in every data generating scenario.
3. To improve the efficiency of the dIVW estimator, we propose two data-
driven methods to select “efficiency-increasing” SNPs for the dIVW
estimator. The first one is straightforward and capable of eliminating
IVs that have no effect on the exposure. The second one uses iterated
thresholding and is able to construct the most efficient estimator in a
given class.
The rest of this paper is organized as follow. Section 2 introduces notation,
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setup, and assumptions. Section 3 characterizes the consistency and asymp-
totic normality of the IVW estimator (1.1) and its pre-screened counterpart
(1.2). Section 4 proposes the dIVW estimator, gives its statistical proper-
ties, and Section 4.1 proposes data-driven IV selection methods. Section 5
studies an extension of dIVW estimator to balanced horizontal pleiotropy
[33, 37, 23]. Results from simulation studies and a real data analysis are
presented in Sections 6 and 7, respectively. The paper concludes with a
discussion in Section 8. Technical proofs are in the supplementary material.
2. Notation, Setup, and Assumption. Following the two-sample
summary-data MR literature [29, 8, 40], we consider p SNPs, Z1, . . . , Zp,
where each SNP Zj takes on values 0, 1 or 2, and all SNPs are mutually
independent from each other through linkage disequilibrium (LD) pruning
or clumping done via software [24]. Let X be the exposure and Y be the
continuous outcome. MR typically assumes the following models,
X =
p∑
j=1
γjZj + ηXU + EX ,(2.1)
Y = β0X + ηY U + EY ,(2.2)
where U is an unmeasured confounder independent of Z1, ..., Zp, EX and
EY are mutually independent random noises that are also independent of
(Z1, . . . , Zp, U), and (γj , ηX , ηY , β0) are unknown parameters. The goal in
an MR analysis is to estimate the effect of the exposure X on the outcome
Y , which is represented by β0. Since U is not observed and possibly re-
lated with X, estimating β0 using model (2.2) with ordinary least squares
leads to biased estimates. Instead, an MR approach to estimating β0 typi-
cally posits both models (2.1) and (2.2) and makes three core assumptions
[19, 32, 5, 27, 25]. The first assumption is that instruments are associated
with the exposure X, which amounts to γj ’s in model (2.1) not simultane-
ously equaling to zero. We call the set of instruments where γj 6= 0 to be
relevant or non-null instruments and the set of instruments where γj = 0
to be null instruments. The second assumption is that instruments are in-
dependent of the unmeasured confounder U ; this is encoded by assuming U
is independent of Z1, . . . , Zp in (2.1)-(2.2). The third and last core assump-
tion is that instruments affect the outcome Y only through the exposure X;
this is true under (2.1)-(2.2) since (2.2) does not involve Zj ’s. However, this
last assumption may be violated in some studies; see Section 5 for details.
For more detailed discussions on the core assumptions, models, and their
implication in MR, see Didelez and Sheehan [20] and Bowden et al. [8].
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In classic IV settings, estimation of β0 is based on n independent and iden-
tically distributed (i.i.d.) observations of (Z1, . . . , Zp, X, Y ). In two-sample
MR, estimation is based on nX i.i.d. observations of (X,Z1, . . . , Zp) from
the exposure dataset, and nY i.i.d. observations of (Y, Z1, . . . , Zp) from the
outcome dataset. The two datasets are assumed to be independent of each
other and we never jointly observe Y and X. In two-sample summary-data
MR, which is the most popular data setting in MR and the setting consid-
ered in the paper, only summary statistics from the exposure and outcome
datasets are observed. Specifically, from the exposure dataset, we observe
γˆj , the ordinary least square estimate from a linear regression of X on Zj ,
and its standard error σXj , j = 1, ..., p. From the outcome dataset, we ob-
serve Γˆj , the ordinary least square estimate from a linear regression of Y
on Zj , and its standard error σY j , j = 1, ..., p. Note that models (2.1)-(2.2)
and the independence of instruments immediately imply that γˆj consistently
estimates γj and Γˆj consistently estimates β0γj for each j.
We make the following assumptions about the summary statistics.
Assumption 1. For every j = 1, . . . , p, σ2Xj and σ
2
Y j are known, γˆj ∼
N(γj , σ
2
Xj), Γˆj ∼ N(β0γj , σ2Y j), and {γˆj , Γˆj , j = 1, ..., p} are mutually inde-
pendent.
We briefly assess the plausibility of Assumption 1 in two-sample summary-
data MR; see Zhao et al. [40] who also make the same assumption. Modern
GWAS usually encompasses tens of thousands of participants and nX and
nY are on the order of 10
4. Hence, the normality of Γˆj and γˆj is plausible.
For the same reason, the standard errors of these estimates are precisely
estimated and assuming them to be known is a reasonable approximation.
The two-sample MR data structure guarantees the independence of γˆj ’s and
Γˆj ’s. Also, two-sample MR prunes/clumps SNPs to be far apart in genetic
distance and each SNP only explains a very small proportion of the total
variance in the exposure variable, making independence between γˆj ’s and
independence between Γˆj ’s likely. Furthermore, if Y is binary, Assumption
1 is a first-order local approximation of a logistic outcome model [40, 41]. In
Section 5, we relax Assumption 1 to allow for balanced horizontal pleiotropy.
Next, we make the following assumption about the standard errors of the
summary statistics.
Assumption 2. Let vj = σXj/σY j. There are positive constants cσ and
c′σ such that cσ ≤ vj ≤ c′σ for all j = 1, ..., p.
To explain Assumption 2, consider the formulas for the standard errors
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of γˆj and Γˆj from ordinary least squares,
σ2Xj =
Var(X)− γ2jVar(Zj)
nXVar(Zj)
and σ2Y j =
Var(Y )− β20γ2jVar(Zj)
nY Var(Zj)
.
The ratio of these two standard errors is
v2j =
σ2Xj
σ2Y j
=
Var(X)− γ2jVar(Zj)
Var(Y )− β20γ2jVar(Zj)
nY
nX
.
If SNP j is a rare variant, then Var(Zj) is small and hence, this ratio is
about nY n
−1
X Var(X)/Var(Y ). When SNP j is a common variant, the terms
γ2jVar(Zj) and β
2
0γ
2
jVar(Zj) are still small compared to Var(X) and Var(Y )
because an individual SNP typically explains a small proportion of the total
variance in the exposure and outcome variables. Thus, if the sample sizes
nX and nY are of the same order, Assumption 2 will hold in both cases.
We conclude this section by defining the average strength of p IVs
(2.3) κ =
1
p
p∑
j=1
µ2j , µj =
γj
σXj
.
Note that µj can be viewed as a z-score of SNP j’s effect on X. If κ is small,
SNPs are, on average, weakly associated with the exposure or there are many
rare variants. If κ is large, SNPs are, on average, strongly associated with
the exposure and there are many common variants. An unbiased estimator
of κ is the average of F-statistics minus 1.
(2.4) κˆ =
1
p
p∑
j=1
γˆ2j
σ2Xj
− 1.
As we will see in later sections, the limiting values of κ in (2.3) plays a key
role in characterizing the properties of the IVW estimator and as such, the
unbiased estimator of κ can serve as a guideline in empirical applications
to check the theoretical conditions underlying the properties of the IVW
estimator.
3. Properties of the IVW Estimator.
3.1. IVW Estimator (1.1). We first study the consistency and asymp-
totic normality of the IVW estimator βˆIVW in (1.1) under different limiting
values of κ defined in (2.3). In what follows,
P−→ denotes convergence in
probability and
D−→ denotes convergence in distribution.
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Theorem 3.1. Suppose Assumptions 1 and 2 hold. The following con-
clusions can be made about the IVW estimator.
(a) If κ/p → ∞, p → ∞ and µ2j/(κp) → 0 for every j, then the IVW
estimator βˆIVW is consistent and asymptotically normal, i.e., βˆIVW
P−→
β0 and
V
−1/2
IVW
(
βˆIVW − β0
)
D−→ N(0, 1),
where
VIVW =
∑p
j=1
[
v2j (µ
2
j + 1) + β
2
0v
4
j (µ
2
j + 2)
]
[∑p
j=1 v
2
j (µ
2
j + 1)
]2 , vj = σXjσY j .
The result still holds if we replace VIVW by a plug-in consistent esti-
mator
VˆIVW =
∑p
j=1
[
v2j µˆ
2
j + βˆ
2
IVWv
4
j (µˆ
2
j + 1)
]
[∑p
j=1 v
2
j µˆ
2
j
]2 , µˆj = γˆjσXj .
(b) If κ→∞, then βˆIVW P−→ β0.
(c) If κ→ c > 0 and p→∞, then
βˆIVW − β0
∑p
j=1 v
2
jµ
2
j∑p
j=1 v
2
j (µ
2
j + 1)
P−→ 0.
(d) If κ→ 0 and p→∞, then βˆIVW P−→ 0.
Consider part (a) of Theorem 3.1, which is the only regime where the
IVW estimator is both consistent and asymptotically normal. The condition
µ2j/(κp)→ 0 for every j says that a single SNP’s strength is small compared
to the total IV strength κp, a reasonable assumption in MR studies. However,
the condition κ/p→∞ requires that the average IV strength κ diverges to
infinity at a faster rate than p. This is extremely unlikely in MR studies
unless every SNP is very strong. For example, even if the magnitude of
squared z-score µ2j grows linearly in p for each SNP j, κ/p still converges to
a constant and the condition fails. However, if µ2j grows quadratically in p,
the condition κ/p → ∞ holds. Unless this latter condition holds for every
SNP, the current practice of inference using normal approximation of βˆIVW
is questionable.
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Part (b) of Theorem 3.1 shows that the IVW estimator is consistent when
the average IV strength goes to infinity, κ → ∞; we remark that unlike
other conditions, condition (b) does not necessarily require p → ∞ and as
such, can also approximate non-growing p regimes. Using the relationship
between F-statistics and κ at the end of Section 2, condition (b) indicates
that the average of p F-statistics must be large for the IVW estimator to be
consistent. We believe a typical MR study would fail this condition as SNPs
in MR are not simultaneously strong and have high average F-statistics.
Combining parts (a) and (b) stresses that the IVW estimator’s consistency
and asymptotic normality strongly rely on having strong IVs.
Part (c) of Theorem 3.1 states that when the average IV strength κ con-
verges to a nonzero constant, the IVW estimator is biased towards 0. This
regime reflects MR studies where a majority of instruments are weak with
small, but non-zero µj ’s. In part (d) of Theorem 3.1, when the average IV
strength κ converges to zero, the IVW estimator converges to 0 in proba-
bility. This regime reflects MR studies where there are many weak and null
IVs. We believe a typical MR study likely falls in regimes (c) and (d), sug-
gesting that using the IVW estimator likely leads to a biased estimate of
the exposure effect β0.
We conclude the section by making two points. First, Theorem 3.1 pro-
vides a theoretical justification of the numerical observations in the literature
concerning the property of the IVW estimator with weak instruments. In
particular, we show that the IVW estimator requires stringent conditions for
asymptotic normality that will typically not be possible in most MR stud-
ies. Having said that, it is not common in MR for an investigator to directly
use the IVW estimator with thousands of SNPs. Instead, many MR inves-
tigators pick the strongest instruments through a pre-screening procedure
and run the IVW estimator among the pre-screened instruments. The next
section illustrates what happens to the IVW estimator when pre-screening
is conducted beforehand.
3.2. IVW Estimator (1.2) with Pre-screening. It is common in MR stud-
ies to pre-screen for strong IVs and to use only the selected IVs in the IVW
estimator. Typically, the pre-screening process selects IVs whose p-values
associated with the effect estimates γˆj ’s are below the GWAS p-value thresh-
old of 5× 10−8. This pre-screening procedure is equivalent to selecting IVs
whose estimated z-scores associated with the effect estimates γˆj ’s are above
the z-score threshold λ ≈ 5.45; this is based on finding the critical value of a
standard normal distribution where its two-sided tail probability equals to
5 × 10−8. To avoid selection bias or the “winner’s curse”, it is usually rec-
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ommended to use a third independent dataset, called the selection dataset,
solely for pre-screening instruments [10, 40]. This section studies the proper-
ties of the IVW estimator (1.2) with pre-screening from a selection dataset.
Formally, the IVW estimator (1.2) with pre-screening can be expressed
as a hard-thresholding estimator with z-score threshold λ ≥ 0,
(3.1) βˆλ,IVW =
∑p
j=1 Γˆj γˆjσ
−2
Y j I(|γˆ∗j | > λσ∗Xj)∑p
j=1 γˆ
2
j σ
−2
Y j I(|γˆ∗j | > λσ∗Xj)
.
Here, the asterisks denote estimates coming from the selection dataset. For
example, γˆ∗j and σ∗Xj are estimates derived from the selection dataset with
γˆ∗j ∼ N(γj , σ∗2Xj). If λ = 0, βˆλ,IVW becomes the original IVW estimator βˆIVW
in equation (1.1).
To incorporate the selection dataset into our analysis, we make assump-
tions similar to Assumptions 1 and 2 that include the selection dataset.
Assumption 1
′
. For every j = 1, . . . , p, σ2Xj, σ
2
Y j, σ
∗2
Xj are known,
γˆj ∼ N(γj , σ2Xj), Γˆj ∼ N(β0γj , σ2Y j), γˆ∗j ∼ N(γj , σ∗2Xj), and {γˆj , Γˆj , γˆ∗j , j =
1, ..., p} are mutually independent.
Assumption 2
′
. There are positive constants cσ, c
′
σ such that cσ ≤
σXj/σY j ≤ c′σ and cσ ≤ σXj/σ∗Xj ≤ c′σ for all j = 1, ..., p.
Let Φ(s) be the cumulative distribution function of the standard normal
distribution and let q∗λ,j = P (|γˆ∗j | > λσ∗Xj) = Φ(µ∗j − λ) + Φ(−µ∗j − λ) be
the probability that instrument j exceeds the threshold λ and is included
in the IVW estimator. Let µ∗j = γj/σ∗Xj be the z-score of instrument j from
the selection dataset, and let µˆ∗j = γˆ∗j /σ∗Xj be the estimated z-score. Similar
to the IVW estimator, we use the expected average strength of IVs under
selection
κ∗λ =
∑p
j=1 µ
2
jq
∗
λ,j∑p
j=1 q
∗
λ,j
,
to characterize the behavior of the pre-screened IVW estimator. We also use
p∗λ =
∑p
j=1 q
∗
λ,j , the expected number of SNPs that are selected during the
pre-screening process, to represent the effective number of IVs used in the
pre-screened IVW estimator (3.1). In particular, if λ = 0 so that all the IVs
are included in the IVW estimator, q∗λ,j , κ
∗
λ, and p
∗
λ become 1, κ, and p,
respectively.
We can obtain an unbiased estimator of p∗λ by counting the number of
IVs selected, pˆ∗λ =
∑p
j=1 I(|γˆ∗j | > λσ∗Xj). We can also obtain a first-order
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approximation of κ∗λ by taking the average of F-statistics among IVs that
are selected from the selection dataset minus 1, i.e.,
κˆ∗λ = pˆ
∗−1
λ
p∑
j=1
µˆ2jI(|γˆ∗j | > λσ∗Xj)− 1.
The following theorem states the conditions under which the pre-screened
IVW estimator in (3.1) is consistent and asymptotically normal.
Theorem 3.2. Suppose Assumptions 1
′
and 2
′
hold. For a given thresh-
old λ, the following conclusions can be made about the pre-screened IVW
estimator.
(a) If κ∗λ/p
∗
λ → ∞, κ∗λ
√
p∗λ/λ
2 → ∞, p → ∞ and µ2jq∗λ,j/κ∗λp∗λ → 0 for
every j, then the pre-screened IVW estimator βˆλ,IVW is consistent and
asymptotically normal, i.e., βˆλ,IVW
P−→ β0 and
V
−1/2
λ,IVW
(
βˆλ,IVW − β0
)
D−→ N(0, 1),
where
Vλ,IVW =
∑p
j=1
[
v2j (µ
2
j + 1)q
∗
λ,j + β
2
0v
4
j (µ
2
j + 3)q
∗
λ,j − β20v4j q∗2λ,j
]
[∑p
j=1 v
2
j (µ
2
j + 1)q
∗
λ,j
]2 .
The result still holds if we replace Vλ,IVW by a plug-in consistent esti-
mator
Vˆλ,IVW =
∑
j:|µˆ∗j |>λ
[
v2j µˆ
2
j + βˆ
2
λ,IVWv
4
j (µˆ
2
j + 1)
]
[∑
j:|µˆ∗j |>λ v
2
j µˆ
2
j
]2 .
(b) If κ∗λ →∞ and κ∗λ
√
p∗λ/λ
2 →∞, then βˆλ,IVW P−→ β0.
(c) If κ∗λ → c > 0 and
√
p∗λ/max(1, λ
2)→∞, then
βˆλ,IVW − β0
∑p
j=1 µ
2
jv
2
j q
∗
λ,j∑p
j=1(µ
2
j + 1)v
2
j q
∗
λ,j
P−→ 0.
(d) If κ∗λ → 0 and
√
p∗λ/max(1, λ
2)→∞, then βˆλ,IVW P−→ 0.
Each part of Theorem 3.2 mirrors each part of Theorem 3.1. For example,
part (a) of Theorem 3.2 states the conditions under which the pre-screened
IVW estimator with threshold λ is consistent and asymptotically normal.
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The condition κ∗λ/p
∗
λ → ∞, the counterpart of κ/p → ∞ in part (a) of
Theorem 3.1, is reasonable when all selected SNPs are strong such that
their expected average IV strength κ∗λ is going to infinity faster than p
∗
λ.
The condition µ2jq
∗
λ,j/(κ
∗
λp
∗
λ) → 0 for every j, like condition µ2j/(κp) → 0
in part (a) of Theorem 3.1, is reasonable if a selected IV’s strength is small
compared to the total expected IV strength among selected instruments.
Part (b) of Theorem 3.2 states the conditions under which the pre-screened
IVW estimator is consistent, i.e., κ∗λ →∞, and mirrors the condition κ→∞
in Theorem 3.1(b). Parts (c) and (d) of Theorem 3.2 refer to settings where
the pre-screened IVW estimator is biased towards zero. Broadly speaking,
these scenarios occur if the pre-screening threshold λ is not large enough
so that many weak and null IVs are selected, or every IV in the selection
dataset is weak. Theorem 4.2 also has an additional assumption involving
the selection threshold λ, which essentially controls the denominator of the
IVW estimator after pre-screening.
Comparing the IVW estimator (1.1) to the pre-screened IVW estima-
tor (1.2), the IVW estimator requires far more stringent conditions on IV
strength (i.e., all p IVs must be strong) to guarantee consistency or asymp-
totic normality. The pre-screened IVW estimator also requires that all se-
lected IVs must be strong, but this condition may be satisfied if we carefully
choose a threshold λ. For example, for consistency, we have to choose λ so
that the average strength of selected IVs κˆ∗λ is large and the product of κˆ
∗
λ
and the square root of the number of selected instruments
√
pˆ∗λ is much
larger than λ2.
Unfortunately, the dependence of the pre-screened IVW estimator on the
tuning parameter λ makes it difficult to verify the pre-screened IVW esti-
mator’s properties in practice. For example, consider the common practice
of selecting IVs that pass the p-value threshold of 5× 10−8, which as men-
tioned earlier is equivalent to setting λ ≈ 5.45. This λ may or may not
satisfy the conditions for consistency or asymptotic normality of βˆλ,IVW and
we highlight some examples below; Table 1 in Section 6 provides numerical
illustrations.
1. If all the non-null IVs are strong and common in the sense that all
µ2j ’s are of order nX , p is in the millions, and the number of samples
in the exposure dataset nX is much larger than the log number of
available SNPs, i.e., log p, conditions in Theorem 3.2(a) may hold and
the pre-screened IV estimator may be asymptotically normal.
2. If all IVs are very weak, for example µ2j ≤ c for all j and some positive
constant c, then κ∗λ is bounded regardless the choice of λ. In this case,
the GWAS threshold may select weak IVs and bias the pre-screened
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dIVW estimator.
3. If every IV strength equals λ, then q∗λ,j ≈ 1/2 and κ∗λ ≈ λ2. But,
κ∗λ/p
∗
λ ≈ 2λ2/p may be small, implying that Theorem 3.2(a) may not
hold.
While the pre-screened dIVW requires less stringent assumptions than the
IVW estimator, we believe that finding a selection threshold λ and checking
that the selected λ satisfies these conditions will be cumbersome. The next
section provides a way to remedy this and estimate β0 without requiring a
selection threshold λ.
4. Debiased IVW Estimator. Motivated by the unrealistic assump-
tions underlying the consistency and asymptotic normality of the IVW esti-
mator as well as the need to carefully choose a threshold λ in the pre-screened
IVW estimator, we propose a simple estimator that does not rely on neither.
We name the new estimator as the debiased IVW (dIVW) estimator. It is
the original IVW estimator multiplied by a bias correction factor, i.e.,
(4.1) βˆdIVW = βˆIVW ·
∑p
j=1wj∑p
j=1(wj − v2j )
.
The bias correction factor
∑p
j=1wj/
∑p
j=1(wj − v2j ) has an explicit form,
where wj = γˆ
2
j σ
−2
Y j and vj = σXj/σY j . Simple algebra reveals that this bias
correction factor essentially replaces and amplifies the denominator of the
IVW estimator in (1.1),
βˆdIVW = βˆIVW ·
∑p
j=1wj∑p
j=1(wj − v2j )
=
∑p
j=1wj βˆj∑p
j=1wj
·
∑p
j=1wj∑p
j=1(wj − v2j )
=
∑p
j=1wj βˆj∑p
j=1(wj − v2j )
=
∑p
j=1 Γˆj γˆjσ
−2
Y j∑p
j=1(γˆ
2
j − σ2Xj)σ−2Y j
.
Surprisingly, this simple correction to the IVW estimator makes it dramat-
ically more robust to many weak IVs. To see why, consider the difference
between the dIVW estimator and the true value β0,
βˆdIVW − β0 =
∑p
j=1(Γˆj γˆj − β0γˆ2j + β0σ2Xj)σ−2Y j∑p
j=1(γˆ
2
j − σ2Xj)σ−2Y j
.
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The numerator of the above expression has exactly mean zero, i.e.,
E{(Γˆj γˆj − β0γˆ2j + β0σ2Xj)σ−2Y j} = (β0γ2j − β0γ2j − β0σ2Xj + β0σ2Xj)σ−2Y j
= 0,
where the first line follows from E(Γˆj) = β0γj , E(γˆj) = γj , E(γˆ
2
j ) = γ
2
j +σ
2
Xj
and the independence between Γˆj and γˆj . The denominator converges to a
positive probability limit under mild conditions; see Theorem 4.1 below.
Thus, we have βˆdIVW
P−→ β0. In contrast, the difference between the IVW
estimator βˆIVW and the true value β0 has the form
βˆIVW − β0 =
∑p
j=1(Γˆj γˆj − β0γˆ2j )σ−2Y j∑p
j=1 γˆ
2
j σ
−2
Y j
.
The expectation of the numerator is
E
 p∑
j=1
(Γˆj γˆj − β0γˆ2j )σ−2Y j
 = p∑
j=1
(β0γ
2
j − β0γ2j − β0σ2Xj)σ−2Y j
= −β0
p∑
j=1
σ2Xjσ
−2
Y j ,
which is not 0 unless β0 = 0. Thus, in order for the IVW estimator to be
consistent, the leftover term in the expectation has to be much smaller than
the denominator, or formally,
∑p
j=1 γˆ
2
j σ
−2
Y j has to dominate
∑p
j=1 σ
2
Xjσ
−2
Y j ;
this is also the condition κ→∞ in Theorem 3.1(b).
The following theorem formalizes the above observations and states the
properties of the dIVW estimator (4.1).
Theorem 4.1. Suppose Assumptions 1 and 2 hold. The following con-
clusions can be made about the dIVW estimator.
(a) If κ
√
p→∞, p→∞ and µ2j/(κp+p)→ 0 for every j, then the dIVW
estimator is consistent and asymptotically normal, i.e., βˆdIVW
P−→ β0
and
V
−1/2
dIVW
(
βˆdIVW − β0
)
D−→ N(0, 1),
where
VdIVW =
∑p
j=1
[
v2j (µ
2
j + 1) + β
2
0v
4
j (µ
2
j + 2)
]
[∑p
j=1 v
2
jµ
2
j
]2 .
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The result still holds if VdIVW is replaced with a plug-in consistent
estimator
VˆdIVW =
∑p
j=1
[
v2j µˆ
2
j + βˆ
2
dIVWv
4
j (µˆ
2
j + 1)
]
[∑p
j=1 v
2
j (µˆ
2
j − 1)
]2 .
(b) If we only assume κ
√
p→∞, then the dIVW estimator is consistent,
i.e., βˆdIVW
P−→ β0.
Examining the conditions in Theorem 4.1, the dIVW estimator is more
robust to weak IVs compared to the original IVW estimator. For example,
the main conditions in Theorem 4.1(a), κ
√
p → ∞ and p → ∞, hold even
when κ is bounded; it even holds if κ→ 0 but at a slower rate than 1/√p. In
contrast, the original IVW estimator is consistent and asymptotically nor-
mal when κ/p→∞ and p→∞. Furthermore, if IVs are common variants,
but are weak in the sense of Staiger and Stock [34] (i.e., γj and σXj are
both of the order n
−1/2
X ), the dIVW estimator still remains consistent and
asymptotically normal as p → ∞. We remark that the consistency condi-
tion in part (b) does not necessarily require p → ∞ and as such, can also
approximate non-growing p regimes.
The rate condition κ
√
p → ∞ in Theorem 4.1 can be interpreted as an
effective sample size for the dIVW estimator and can be estimated by κˆ
√
p
with κˆ defined in (2.4). In our simulation studies (i.e., Figure 1), we provide
some guidelines on what would be considered a large value of κˆ
√
p for the
asymptotics promised in Theorem 4.1 to kick in. This is akin to qualitative
guidelines on what would be a large enough n for a normal approximation
of an estimator to hold. The rate condition is also related to conditions
imposed by the limited information maximum likelihood (LIML) estimator
in the one-sample individual-level data setting [15] and the robust adjusted
profile score (MR-raps) estimator [40]. We remark that the latter requires
all SNPs to be common variants whereas the dIVW estimator can handle
both common and rare variants.
4.1. Improving Efficiency of dIVW with Pre-Screening. While the dIVW
estimator is consistent and asymptotically normal even if many IVs are
weak, a closer inspection of its variance VdIVW in Theorem 4.1 suggests that
including null IVs increases variance. The goal of this section is to explore
how to make the dIVW estimator more efficient by pre-screening for non-
null IVs. We remark that in this section, we use pre-screening to improve
efficiency of the dIVW estimator; in contrast, the IVW estimator uses pre-
screening to reduce bias.
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Formally, consider the dIVW estimator using only IVs selected from the
selection dataset.
(4.2) βˆλ,dIVW =
∑p
j=1 Γˆj γˆjσ
−2
Y j I(|γˆ∗j | > λσ∗Xj)∑p
j=1(γˆ
2
j − σ2Xj)σ−2Y j I(|γˆ∗j | > λσ∗Xj)
.
Theorem 4.2 states the properties of βˆλ,dIVW.
Theorem 4.2. Suppose Assumptions 1′ and 2′ hold. For a given λ, the
following conclusions can be made about the pre-screened dIVW estimator.
(a) If κ∗λ
√
p∗λ/max(1, λ
2) → ∞, p → ∞ and µ2jq∗λ,j/(κ∗λp∗λ + p∗λ) → 0 for
every j, then the pre-screened dIVW estimator (4.2) is consistent and
asymptotically normal, i.e., βˆλ,dIVW
P−→ β0 and
V
−1/2
λ,dIVW
(
βˆλ,dIVW − β0
)
D−→ N(0, 1),
where
Vλ,dIVW =
∑p
j=1
[
v2j (µ
2
j + 1) + β
2
0v
4
j (µ
2
j + 2)
]
q∗λ,j[∑p
j=1 v
2
jµ
2
jq
∗
λ,j
]2 .
The same result holds if we replace Vλ,dIVW by a plug-in consistent
estimator
Vˆλ,dIVW =
∑
j:|µˆ∗j |>λ
[
v2j µˆ
2
j + βˆ
2
λ,dIVWv
4
j (µˆ
2
j + 1)
]
[∑
j:|µˆ∗j |>λ v
2
j (µˆ
2
j − 1)
]2 .
(b) If we only assume κ∗λ
√
p∗λ/max(1, λ
2) → ∞, then the pre-screened
dIVW estimator is consistent, i.e., βˆλ,dIVW
P−→ β0.
We remark that the conditions for the pre-screened dIVW estimator (4.2)
are weaker than those for the pre-screened IVW estimator (1.2) stated in
Theorem 3.2. For example, the condition for consistency of the pre-screened
IVW estimator implies the condition κ∗λ
√
p∗λ/max(1, λ
2) → ∞ which is re-
quired for the consistency of pre-screened dIVW estimator. Also, the rate
condition κ∗λ
√
p∗λ/max(1, λ
2) →∞ acts like an effective sample size for the
pre-screened dIVW estimator and can be estimated by κˆ∗λ
√
pˆ∗λ/max(1, λ
2).
In our simulation studies, specifically Figure 1, we provide some guidelines
on what would be considered a large effective sample size for the asymptotics
promised in Theorem 4.2 to kick in.
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The variance of the pre-screened dIVW estimator in Theorem 4.2 provides
a basis to choose the threshold λ to improve efficiency of the dIVW estima-
tor. In general, the threshold λ has to satisfy the conditions in Theorem 4.2
as well as reduce the variance Vλ,dIVW.
A natural choice is the threshold λ =
√
2 log p which guarantees that the
probability of selecting any null instrument is very small.
P (at least one null IV is selected) = 2(p− s)Φ(−λ)
≤ 2(p− s) 1
λ
√
2pi
e−λ
2/2
=
2√
2pi
1√
2 log p
p− s
p
→ 0 as p→∞
For example, suppose we have an MR study where we have a few strong and
common variant SNPs with z-scores on the order of nX and the other rele-
vant SNPs satisfy µ2j ≥
√
2 log p−c for some constant c. Then, the condition
in Theorem 4.2(a), κ∗λ
√
p∗λ/max(1, λ
2)→∞ is satisfied by nX/(
√
s log p)→
∞. We remark that λ = √2 log p is an improvement over the common cut-
off based on the p-value threshold of 5 × 10−8 (i.e., λ ≈ 5.45) because
λ =
√
2 log p adapts to the total number of IVs. More concretely, if the
initial number of candidate SNPs in the selection dataset is smaller than a
million, i.e., p < 106, then
√
2 log p < 5.45 and the proposed pre-screening
cutoff λ =
√
2 log p selects more IVs than the genome-wide p-value cutoff
5×10−8. The net effect is that we can include more non-null IVs to improve
the efficiency of dIVW estimator.
However, λ =
√
2 log p is not necessarily optimal in the sense that it
also removes many weak, but non-null IVs. Indeed, the
√
2 log p threshold is
mainly designed to minimize the probability of not selecting any null IVs; it
isn’t designed to minimize the asymptotic variance of βˆλ,dIVW. Therefore, we
propose another approach, which we call the MR-EO algorithm, to choose λ
that directly minimizes the asymptotic variance Vλ,dIVW; MR-EO stands for
Mendelian Randomization Estimation-Optimization. In a nutshell, MR-EO
considers a range of estimates βˆλ,dIVW for λ ∈ [0,
√
2 log p], where λ = 0
amounts to including every IV and λ =
√
2 log p may select very few IVs.
It then tries to find the optimal λ in this range such that the asymptotic
variance is minimized.
Formally, suppose κ∗λ
√
p∗λ/max(1, λ
2)→∞ holds for every λ in the range
[0,
√
2 log p]. Then, every βˆλ,dIVW is consistent. Also, for a given λ, its vari-
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ance estimator is
Vˆλ,dIVW(β0) =
∑
j:|µˆ∗j |>λ
[
v2j µˆ
2
j + β
2
0v
4
j (µˆ
2
j + 1)
]
[∑
j:|µˆ∗j |>λ v
2
j (µˆ
2
j − 1)
]2 .
Then, the most efficient estimator βˆλ,dIVW among λ ∈ [0,
√
2 log p] uses λ
that minimizes Vˆλ,dIVW(β0). However, Vˆλ,dIVW(β0) can only be computed
with a known β0. MR-EO resolves this by alternating between estimating
the exposure effect β0 (i.e., the E-Step), and finding the optimal λ given an
estimated β0 (i.e., the O-Step); see Algorithm 1 for details.
Initialize t = 0, tmax, λ0 =
√
2 log p, V =∞;
while t ≤ tmax do
E-Step: for a given λt, estimate β0 with the dIVW estimator βˆλt,dIVW;
if V ≤ Vˆλt,dIVW(βˆλt,dIVW) then
exit the while loop;
else
V = Vˆλt,dIVW(βˆλt,dIVW);
end
O-Step: Plug βˆλt,dIVW into the variance estimator and find
λt+1 = arg min
λ∈[0,
√
2 log p]
Vˆλ,dIVW(βˆλt,dIVW)
Set t = t+ 1;
end
Output λt−1.
Algorithm 1: MR-EO algorithm to determine the optimal λ
We make some comments regarding the implementation of MR-EO and
its final output. First, we initialize MR-EO to λ0 =
√
2 log p and force the
algorithm to stop at t = tmax with a reasonably large tmax, mainly for
computational efficiency. Second, if the estimator of β0 is inconsistent for
some values of λ, the algorithm may fail to find the optimal λ. To avoid
this, we can empirically evaluate κˆ∗λ
√
pˆ∗λ/max(1, λ
2) and make sure this
quantity is reasonably large for all λ in the specified range. In our simulation
studies, we find that setting the range of λ to be 0 and
√
2 log p works
well. Other range of λ besides [0,
√
2 log p] can also be used so long as all
the estimators with λ in the range is consistent for β0. Third, there is no
theoretical guarantee that the estimator chosen by MR-EO is asymptotically
normal. Nevertheless, in our simulation studies in Section 6, we find that the
estimator chosen by MR-EO is consistent and the constructed confidence
interval has desirable coverage probability.
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5. Balanced Horizontal Pleiotropy. In this section, we study the
property of the dIVW estimator under one type of pleiotropy in MR, bal-
anced horizontal pleiotropy [23, 40, 8]. Under balanced horizontal pleiotropy,
the third core IV assumption described in Section 2 is violated. Specifically,
the pleiotropic effects of p SNPs α1, ..., αp are random effects that are nor-
mally distributed with mean zero. These effects are added into the relation-
ship between Y , X, and Zj ’s.
(5.1) Y = β0X +
p∑
j=1
αjZj + ηY U + EY .
In short, under balanced horizontal pleiotropy, model (5.1) replaces (2.2)
and model (2.1) remains the same as before. The random effects αj ’s are
independent of X, Zj ’s, U , EY and EX .
To incorporate balanced pleiotropy, we replace Assumptions 1′ and 2′ with
the following assumptions.
Assumption 3. For every j = 1, . . . , p, σ2Xj, σ
2
Y j, σ
∗2
Xj are known, γˆj ∼
N(γj , σ
2
Xj), Γˆj ∼ N(αj + β0γj , σ2Y j), γˆ∗j ∼ N(γj , σ∗2Xj), αj ∼ N(0, τ20 ), and
the variables in the set {γˆj , Γˆj , γˆ∗j , j = 1, ..., p} are mutually independent.
Assumption 4. There are positive constants cσ, c
′
σ, cτ such that cσ ≤
σXj/σY j ≤ c′σ, cσ ≤ σXj/σ∗Xj ≤ c′σ and τ0 ≤ cτσY j for all j.
Theorem 5.1 shows that the pre-screened dIVW estimator remains con-
sistent and asymptotically normal under balanced horizontal pleiotropy.
Theorem 5.1. Suppose Assumptions 3 and 4 hold. For a given λ, the
following conclusions can be made about the pre-screened dIVW estimator.
(a) If κ∗λ
√
p∗λ/max(1, λ
2) → ∞, p → ∞ and µ2jq∗λ,j/(κ∗λp∗λ + p∗λ) → 0
for every j, then the pre-screened dIVW estimator is consistent and
asymptotically normal, i.e., βˆλ,dIVW
P−→ β0, and
W
−1/2
λ,dIVW
(
βˆλ,dIVW − β0
)
D−→ N(0, 1),
where
Wλ,dIVW =
∑p
j=1
[
v2j (1 + τ
2
0σ
−2
Y j )(µ
2
j + 1) + β
2
0v
4
j (µ
2
j + 2)
]
q∗λ,j[∑p
j=1 v
2
jµ
2
jq
∗
λ,j
]2 .
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Additionally, if there exists a constant c > 0 such that
(5.2) pσ−2Y j ≤ c
p∑
k=1
σ−2Y k for every j,
and κ
√
p→∞, then the same result holds if we replace Wλ,dIVW with
a plug-in consistent estimator
Wˆλ,dIVW =
∑
j:|µˆ∗j |>λ
[
v2j (1 + τˆ
2σ−2Y j )µˆ
2
j + βˆ
2
λ,dIVWv
4
j (µˆ
2
j + 1)
]
[∑
j:|µˆ∗j |>λ v
2
j (µˆ
2
j − 1)
]2 ,
τˆ2 =
∑p
j=1
[
(Γˆj − βˆdIVWγˆj)2 − σ2Y j − βˆ2dIVWσ2Xj
]
σ−2Y j∑p
j=1 σ
−2
Y j
.
(b) If we only assume κ∗λ
√
p∗λ/max(1, λ
2) → ∞, then the pre-screened
dIVW estimator is consistent, i.e., βˆλ,dIVW
P−→ β0.
We remark that Theorem 5.1 recovers the dIVW estimator without pre-
screening by setting λ = 0. The major difference between the performance
of the dIVW estimator without balanced pleiotropy and with balanced
pleiotropy is in the variance Wλ,dIVW. In particular, Condition (5.2) is
assumed to guarantee the consistency of the plug-in variance estimator
Wˆλ,dIVW and is reasonable if σ
2
Y j ’s are not too different from each other.
Note that we use the dIVW without pre-screening to estimate τˆ2 for sim-
plicity. Also, we can still use the aforementioned methods (e.g., MR-EO) to
choose λ and improve efficiency.
6. Simulation Studies.
6.1. Comparison Between Estimators and Pre-Screening Thresholds. We
conduct simulation studies to evaluate the finite sample behavior of the
proposed estimators. To closely mirror what is done in practice, we take a
real two-sample summary-level MR data from the BMI-CAD dataset in the
mr.raps R package (version 0.3.1) of Zhao et al. [41] and use the values from
the dataset as our simulation parameters. The dataset is used to estimate
the effect of body mass index (BMI), i.e., X, on the risk of coronary artery
disease (CAD), i.e., Y . There are three non-overlappping GWASs in the
dataset:
1. Selection dataset: A GWAS for BMI in the Japanese population (sam-
ple size: 173,430) [2];
20 YE ET AL.
2. Exposure dataset: A GWAS for BMI in round 2 of the UK BioBank
(sample size: 336,107) [1];
3. Outcome dataset: A GWAS for CAD from the CARDIoGRAMplusC4D
consortium (sample size: ≈185,000), with genotype imputation using
the 1000 Genome Project [36].
The three datasets have been cleaned so that (i) SNPs appear in all three
datasets and (ii) SNPs are far apart in genetic distance; see Zhao et al. [41]
for details. The data cleaning leads to p = 1119 SNPs available for analysis.
Each GWAS contains publicly available summary statistics that include the
coefficients and standard errors from marginal linear or logistic regression of
the trait in question to each SNP. From the exposure dataset, the estimated
average IV strength is κˆ = 6.8. From the selection dataset, the estimated
average IV strength is κˆ = 7.7.
Let s denote the number of non-null instruments. We consider three sim-
ulation settings for the exposure and selection datasets that are plausible in
an MR study. Broadly speaking, each of these settings change the number
of null IVs from the set of 1119 SNPs.
Case 1 (Some strong IVs, many null IVs): p = 1119, s = 20, κ = 2.90. For
the s = 20 non-null instruments, we set the true marginal IV-exposure
association parameters γj ’s to be those from the top 20 genetic variants
with the smallest p-values in the exposure dataset.
Case 2 (Many weak IVs, many null IVs): p = 1119, s = 100, κ = 1.05. This
setting is similar to Case 1, except we use the first 100 SNPs in the
exposure dataset.
Case 3 (Many weak IVs, no null IVs): p = s = 1119, κ = 7.78. This setting is
similar to Case 1, except we use all 1119 SNPs.
For each setting, we generate the simulated exposure and selection datasets
based on Assumptions 1′ and 2′. Specifically, for non-null IVs, we set γj ’s
according to each simulation setting and set the true variances σ∗2Xj and σ
2
Xj
for non-null IVs to be the corresponding estimated variances in the BMI
datasets. For null IVs, we set their γj ’s to be zero and set their variances
σ∗2Xj and σ
2
Xj based on taking a random sample of the estimated variances in
the BMI dataset. Finally, for the outcome dataset, we set the true marginal
IV-outcome association parameter Γj to be Γj = β0γj with β0 = 0.4 and
γj from the exposure dataset. Like the exposure and selection datasets, the
true variances σ2Y j of the marginal IV-outcome model correspond to the
estimated variances from the outcome dataset.
We compare seven MR methods: the IVW estimator introduced in Sec-
tion 3, the dIVW estimator proposed in Section 4, and five other methods
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in the literature, MR-Egger regression [6], weighted median estimator (MR-
median) [7], weighted mode estimator (MR-mode) [22], profile score estima-
tor (MR-raps) [40], and profile score with empirical partially Bayes shrinkage
weights (MR-raps-shrink) [41]. MR-Egger, MR-median and MR-mode are
implemented using the MendelianRandomization R package (version 0.4.1)
[39]. To make the comparisons fair, we use the l2 loss while implement-
ing MR-raps via the mr.raps package. For every estimator except MR-raps
and MR-rap-shrink, we also use different pre-screening procedures, including
λ = 0 (no thresholding, all SNPs are included), λ = 5.45131 (p-value cutoff
based on the p-value threshold of 5× 10−8), and λ = √2 log p (≈ 3.75 when
p = 1119). We also include the dIVW estimator with λ determined by the
MR-EO algorithm with the maximum number of iterations set to tmax = 5
and using the optimize function from R in the O-step. The standard errors of
the IVW and dIVW estimators are estimated from the variance estimators
in Theorem 4.2 or 5.1.
Table 1 shows the mean and standard deviation of each estimator. It
also shows the average length and coverage probability of 95% confidence
intervals (CI). Under all scenarios, the IVW estimator without pre-screening
(i.e., λ = 0) is biased towards zero, which agrees with our theoretical result
since the average IV strength κ’s are relatively small. The IVW estimator’s
coverage probabilities are far from 95% due to the downward bias and the
inaccurate normal approximation. The pre-screened IVW estimator under
the threshold λ = 5.45 or
√
2 log p improves the performance of the IVW
estimator substantially, which again agrees with our theory that the pre-
screened IVW estimator requires less stringent assumptions for consistency
and asymptotic normality.
The proposed dIVW estimator is robust against weak and null IVs and
shows great performance across all simulation scenarios, with and without
pre-screening. This observation agrees with our theoretical assessment that
the dIVW estimator requires far less stringent conditions for consistency
and asymptotic normality than the IVW estimator. The pre-screened dIVW
estimator does improve upon the dIVW estimator by having a smaller vari-
ance and a shorter confidence interval, while having no impact on bias and
coverage.
Without pre-screening, MR-Egger, MR-median and MR-mode are biased
when the average IV strength is small. In particular, the MR-mode without
pre-screening can be severely biased with unrealistically wide confidence in-
terval. MR-Egger, MR-median and MR-mode thresholded at 5.45 or
√
2 log p
generally have wider confidence intervals compared to the dIVW estimators
thresholded at the same level. Also, even with thresholding, these three
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Table 1
Simulation results for Case 1- Case 3 based on 10,000 repetitions with p = 1119
candidate instruments. The true effect is β0 = 0.4. SD represents standard deviation,
length represents the average length of the 95% CI, and CP represents the empirical
coverage probability of the 95% CI.
Case Method λ mean SD length CP
1 IVW 0 0.260 0.069 0.269 46.92
s = 20 IVW 5.45 0.398 0.094 0.366 94.82
κ = 2.90 IVW
√
2 log p 0.398 0.087 0.341 95.10
dIVW 0 0.402 0.107 0.419 95.20
dIVW 5.45 0.401 0.095 0.368 94.86
dIVW
√
2 log p 0.401 0.087 0.343 95.12
dIVW MR-EO 0.400 0.086 0.337 95.06
MR-Egger 0 0.335 0.082 0.322 87.52
MR-Egger 5.45 0.390 0.240 1.005 96.00
MR-Egger
√
2 log p 0.389 0.205 0.840 95.60
MR-median 0 0.371 0.110 0.477 96.27
MR-median 5.45 0.398 0.118 0.501 96.51
MR-median
√
2 log p 0.397 0.113 0.486 96.70
MR-mode 0 0.033 74 296293 100
MR-mode 5.45 0.395 0.139 0.591 97.14
MR-mode
√
2 log p 0.395 0.142 0.616 97.15
MR-raps 0 0.401 0.105 0.413 95.16
MR-raps-shrink 0 0.400 0.086 0.336 95.12
2 IVW 0 0.159 0.091 0.354 23.94
s = 100 IVW 5.45 0.397 0.206 0.806 95.05
κ = 1.05 IVW
√
2 log p 0.394 0.183 0.717 94.88
dIVW 0 0.404 0.233 0.912 95.39
dIVW 5.45 0.400 0.207 0.811 95.10
dIVW
√
2 log p 0.400 0.186 0.728 94.87
dIVW MR-EO 0.396 0.167 0.655 95.00
MR-Egger 0 0.231 0.122 0.483 72.28
MR-Egger 5.45 0.388 0.948 3.787 96.22
MR-Egger
√
2 log p 0.385 0.359 1.508 95.77
MR-median 0 0.276 0.152 0.668 91.31
MR-median 5.45 0.396 0.228 0.959 96.60
MR-median
√
2 log p 0.394 0.216 0.925 96.93
MR-mode 0 -1.062 130 306245 100
MR-mode 5.45 0.387 0.267 1.141 97.00
MR-mode
√
2 log p 0.39 0.237 1.123 97.10
MR-raps 0 0.398 0.224 0.884 94.91
MR-raps-shrink 0 0.399 0.160 0.625 95.24
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3 IVW 0 0.352 0.047 0.185 82.60
s = 1119 IVW 5.45 0.395 0.086 0.340 95.41
κ = 7.78 IVW
√
2 log p 0.392 0.068 0.270 94.99
dIVW 0 0.400 0.054 0.210 94.70
dIVW 5.45 0.399 0.087 0.343 95.43
dIVW
√
2 log p 0.399 0.070 0.275 95.42
dIVW MR-EO 0.400 0.054 0.210 94.79
MR-Egger 0 0.372 0.066 0.262 93.11
MR-Egger 5.45 0.383 0.189 0.776 95.37
MR-Egger
√
2 log p 0.372 0.132 0.534 95.01
MR-median 0 0.375 0.079 0.354 96.64
MR-median 5.45 0.394 0.114 0.49 96.81
MR-median
√
2 log p 0.391 0.100 0.436 96.86
MR-mode 0 0.750 84 91149 100
MR-mode 5.45 0.391 0.125 0.551 96.77
MR-mode
√
2 log p 0.385 0.260 1.974 97.62
MR-raps 0 0.400 0.054 0.210 94.90
MR-raps-shrink 0 0.400 0.053 0.209 94.71
methods (MR-Egger, MR-median and MR-mode) have larger biases than
the dIVW estimator because they inherently rely on using the ratio estima-
tor βˆj .
The MR-raps without thresholding performs well with respect to bias and
coverage and is comparable to the dIVW estimator with respect to bias, cov-
erage length, and coverage probability. The dIVW estimator with a thresh-
old chosen by MR-EO performs as well as the MR-raps-shrink, the most
efficient among the MR-raps estimators. MR-raps-shrink can have slightly
smaller standard errors than the most efficient dIVW estimator. But, the
method is computationally more complicated and may not have unique so-
lution as mentioned in [41]. In contrast, the dIVW estimator is much simpler
and has an explicit, unique solution.
Table 2 presents the results on the number of total IVs and non-null IVs
selected based on different pre-screening thresholds. We see from Table 2
that the number of non-null IVs selected based on genome-wide significance
(p-value ≤ 5 × 10−8 or λ ≈ 5.45) is very small compared with s, the true
number of non-null IVs; this is especially true under Case 2 and Case 3
when IVs are weak. Taking the theoretically motivated λ =
√
2 log p im-
proves upon the genomic threshold, but it still eliminates too many IVs
when IVs are weak (Cases 2 and 3). The proposed MR-EO algorithm does
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Table 2
Average number of total IVs and non-null IVs selected from the selection dataset of
p = 1119 IVs under different pre-screening thresholds.
λ = 5.45 λ =
√
2 log p MR-EO
Case total non-null total non-null total non-null
1, s = 20, κ = 2.90 12.8 12.8 18.4 18.2 27.0 19.8
2, s = 100, κ = 1.05 3.9 3.9 9.2 9.0 63.2 27.8
3, s = 1119, κ = 7.78 23.8 84.4 1019.6
the best, although it doesn’t always select the correct number of non-null
IVs especially under Case 2. Nevertheless, as seen above, MR-EO as applied
to the dIVW estimator, increases efficiency and shortens CI length without
increasing bias or losing coverage.
Overall, there are three takeaways from the simulation study. First, the
dIVW estimator with or without pre-screening always outperforms the IVW
estimator. Second, for an MR estimator that is robust to weak IVs (e.g.,
dIVW), if a selection dataset is available and pre-screening is applied, we
suggest the threshold used in the pre-screening process should be based on
λ =
√
2 log p instead of the usual cutoff λ ≈ 5.45. Third, to improve efficiency
of an estimator that is robust to weak IVs, (e.g., dIVW), we recommend
using the MR-EO algorithm to adaptively choose λ.
In the supplementary material, we conduct a simulation study under bal-
anced horizontal pleiotropy. In summary, the results are nearly identical to
Case 3 without pleiotropy in that our dIVW estimator shows robustness
against weak and balanced pleiotropic IVs.
6.2. Empirical Guidelines for Asymptotics. In practice with real data,
it is important to have some sense of what is “a large enough” sample size
for the asymptotic results in the paper to be a good approximation. Many
researchers in MR have conducted such analysis for the IVW estimator, most
notably [10]. Here, we conduct a similar analysis for the dIVW estimator
through a small simulation study. Specifically, we examine what would be
a “large” effective sample size, as measured by κ∗λ
√
p∗λ/max(1, λ
2), for the
asymptotics promised by Theorem 4.2 to be plausible.
The setting is identical to Case 3. We choose a grid of 100 equally spaced
λ’s between 0 and 10. For each λ, we generate 1,000 simulation datasets with
the given simulation parameters and calculate the corresponding βˆλ,dIVW for
each dataset. Figure 1 plots these βˆλ,dIVW values against κˆ
∗
λ
√
pˆ∗λ/max(1, λ
2)
(dots) together with the two standard error bands centered at β0 (shaded
area).
We find that for any λ, the coverage probability for the pre-screened
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Fig 1. Evaluation of the consistency and asymptotic normality condition for the dIVW
estimator in Theorem 4.2 under Case 3. The x-axis plots the condition that governs the
asymptotic rate of the dIVW estimator. The y-axis plots the dIVW estimator. The shaded
area represents two-standard error bands centered at β0.
dIVW estimator is around 95% and ranges from 93.5% to 96.0%. However,
as κˆ∗λ
√
pˆ∗λ/max(1, λ
2) grows larger, we saw fewer estimates far from β0, an
indication that asymptotics have “kicked in.” This appears to occur when
κˆ∗λ
√
pˆ∗λ/max(1, λ
2) is greater than 20. Based on this, we recommend that
users of dIVW check to make sure that κˆ∗λ
√
pˆ∗λ/max(1, λ
2) is at least greater
than 20 as part of diagnostic checks for the dIVW estimator.
7. Real Data Example. We apply our methods to the BMI-CAD ex-
ample described in Section 6. Table 3 summarizes the results, where dIVWα
denotes the dIVW estimator developed under balanced horizontal pleiotropy,
MR-rapsα and MR-raps-shrinkα are MR-raps estimators that account for
balanced pleiotropy by setting the over.dispersion parameter in the mr.raps
R package to be TRUE.
Overall, except for the MR-mode estimator without any pre-screening
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Table 3
Point estimates and the estimated standard errors (in parentheses) from different MR
methods in the BMI-CAD example. Each column represents different λ thresholds for
pre-screening. MR-EO selects slightly different λ depending on whether the dIVW or
dIVWα are used; the left-hand side of the semicolon refers to the dIVW estimator and
the right-hand size of the semicolon refers to the dIVWα estimator.
λ 0 5.45
√
2 log p = 3.75 MR-EO
number of IVs selected 1119 44 165 1029; 1023
κˆ∗λ 6.8 72.9 28.1 7.2; 7.3
κˆ∗λ
√
pˆ∗λ/max(1, λ
2) 226.8 16.3 25.7 232.4; 233.1
IVW 0.315 (0.050) 0.282 (0.084) 0.319 (0.068)
dIVW 0.365 (0.058) 0.287 (0.085) 0.331 (0.071) 0.345 (0.058)
dIVWα 0.365 (0.067) 0.287 (0.100) 0.331 (0.082) 0.345 (0.067)
MR-raps 0.382 (0.061) 0.291 (0.086) 0.339 (0.072)
MR-rapsα 0.367 (0.067) 0.297 (0.120) 0.337 (0.090)
MR-raps-shrink 0.388 (0.060) 0.292 (0.086) 0.341 (0.072)
MR-raps-shrinkα 0.374 (0.067) 0.298 (0.120) 0.339 (0.090)
MR-Egger 0.386 (0.077) 0.513 (0.184) 0.390 (0.129)
MR-median 0.322 (0.097) 0.278 (0.124) 0.304 (0.116)
MR-mode 0.739 (402.9) 0.499 (0.402) 0.488 (4.241)
and the MR-Egger method using the threshold λ = 5.45, all the estimated
exposure effects are within two standard errors of each other. We also suspect
the IVW estimator is slightly biased towards zero when λ = 0 since its
point estimator is smaller than that from the dIVW estimator, which is
generally unbiased with weak IVs. We notice that selecting IVs based on
genome-wide significance (i.e., λ = 5.45) generally leads to larger estimated
standard errors across all methods. Except for the IVW estimator, the dIVW
estimator has the smallest standard errors among all MR estimators across
the three choices of λ. Also, the dIVW estimator using λ selected by the MR-
EO algorithm has the smallest standard error while having a point estimator
that is similar to the other methods. Comparing thresholds, we generally
recommend using λ =
√
2 log p for all methods that are not sensitive to
weak IVs because this threshold adapts to the dimension p and includes
more relevant IVs than a static threshold of λ = 5.45 based on the genome-
wide significance level.
We also conduct diagnostics to assess the plausibility of Assumption 1 in
the real dataset. Specifically, when Assumption 1 holds, we have κ
√
p→∞,
βˆdIVW is close to β0, and the standardized residuals,
Γˆj − βˆdIVWγˆj√
σ2Y j + βˆ
2
dIVWσ
2
Xj
, j = 1, ..., p,(7.1)
should follow a standard normal distribution. Following [40], we construct
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a Quantile-Quantile (QQ) plot of the standardized residuals to check As-
sumption 1. Figure 2 shows the result. Since the residuals line up close to
the 45-degree line, Assumption 1 is likely to hold for this example. In the
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Fig 2. Quantile-Quantile plot of the standardized residuals in (7.1) against a standard
normal.
supplementary material, we also assess the plausibility of Assumption 3 by
using a similar strategy as in Figure 2. The QQ plot for Assumption 3 looks
similar to Figure 2. In total, Assumptions 1 and 3 are plausible with the
data.
8. Discussion. In this paper, we analyze the behavior of the inverse-
variance weighted (IVW) estimator and the pre-screened IVW estimator in
two-sample summary-data Mendelian randomization studies. We show that
the IVW estimator requires stringent assumptions on the average strength of
instruments for consistency or asymptotic normality. The pre-screened IVW
estimator requires careful choice of the p-value threshold in the selection
dataset for the desired statistical properties. We then propose a simple mod-
ification of the IVW estimator, called the debiased IVW (dIVW) estimator.
The dIVW estimator is drastically more robust to many weak instruments
than the IVW estimator and performs well with or without pre-screening.
We also show that the common pre-screening practice of selecting strong
instruments based on a p-value cutoff at 5 × 10−8 may eliminate majority
of relevant IVs. In order to increase estimation efficiency of the dIVW esti-
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mator, we then propose two approaches of choosing SNPs via λ, one based
on λ =
√
2 log p that effectively eliminates null IVs and the other that uses
the MR-EO algorithm to directly maximize efficiency.
Based on our theoretical and simulation works, we make two recommenda-
tions for two-sample summary-data Mendelian randomization studies. First,
we argue that the dIVW estimator without pre-screening should be the de-
fault, baseline estimator for two-sample summary-data Mendelian random-
ization studies instead of the IVW estimator. It is as simple as the IVW es-
timator, requiring one to multiply the IVW estimator with a bias-correction
factor, and has provable robustness against many weak instruments and
balanced horizontal pleiotropy. If an independent selection dataset is not
available, including every SNP in dIVW can still lead to a consistent and
asymptotically normal dIVW estimator. Also, the dIVW estimator’s perfor-
mance should serve as the baseline for investigating more complex pleiotropy
as the dIVW estimator effectively eliminates concerns for weak instruments
in most MR settings. Second, to improve efficiency of the dIVW estimator,
and if an independent selection dataset is available, we generally recom-
mend a thresholding value of λ =
√
2 log p on the selection dataset instead
of the commonly used genome-wide significance p-value threshold so that
the threshold adapts to the initial pool of IVs. We also recommend using
the proposed MR-EO algorithm to adaptively select λ and maximize estima-
tion efficiency. Future work will explore how to modify the dIVW estimator
to be robust against other types of pleiotropy.
SUPPLEMENTARY MATERIAL
Supplementary Material: Debiased Inverse-Variance Weighted
Estimator in Two-Sample Summary-Data Mendelian Randomiza-
tion
(doi: COMPLETED BY THE TYPESETTER; .pdf). We provide simula-
tion results under balanced horizontal pleiotropy and theoretical proofs for
the theorems in the paper.
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